The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk

AKSOY F., GULER S., KAHRAMAN F., KUYUMCU M. S. , BAĞCI A., BAS H. A. , ...More

BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, vol.34, no.5, pp.535-541, 2019 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 34 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.21470/1678-9741-2019-0062
  • Journal Name: BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.535-541
  • Keywords: Atrial Fibrilation, Stroke, Metabolic Syndrome, Coronary Artery Disease, Brain Ischemia, Thromboembolism, Hypertension, ATRIAL-FIBRILLATION, OXIDATIVE STRESS, ATHEROSCLEROSIS, PROGRESSION, MANAGEMENT, COMMUNITY, HEART

Abstract

Introduction: Metabolic syndrome (MetS) is defined as an association between diabetes, hypertension, obesity and dyslipidemia and an increased risk of cardiovascular disease. Mitral annular calcification (MAC) is associated with several cardiovascular disorders, including coronary artery disease, atrial fibrillation (AF), heart failure, ischemic stroke and increased mortality. The CHA(2)DS(2)-VASc score is used to estimate thromboembolic risk in AF. However, the association among MAC, MetS and thromboembolic risk is unknown and was evaluated in the current study.